PHI with Smoker's cough
How does this condition affect your private health insurance?
Raucherhusten, or smoker's cough, is a persistent cough common among individuals who smoke. It results from irritation and inflammation of the airways caused by chemicals and particulate matter in tobacco smoke, leading to increased mucus production and impaired ciliary function. This chronic cough often produces phlegm and is typically worse in the morning. While often dismissed as a harmless byproduct of smoking, it is a significant warning sign. Without smoking cessation, Raucherhusten frequently progresses to more severe conditions like chronic bronchitis, emphysema, and chronic obstructive pulmonary disease (COPD), indicating cumulative lung damage and increased risk for other serious health issues, including lung cancer and heart disease. It signifies ongoing harm to the respiratory system.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 20%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months; often becomes chronic with continued smoking.
Duration of Illness (Lifetime)
Chronic, lifelong condition if smoking continues; reversible with sustained smoking cessation, especially in early stages.
Cost of Treatment (Initial)
Minimal (e.g., over-the-counter cough remedies) to moderate (doctor visits, diagnostic tests to rule out other conditions like lung cancer).
Cost of Treatment (Lifetime)
Moderate to very high if it progresses to severe smoking-related diseases like COPD (e.g., long-term medications, hospitalizations, oxygen therapy, rehabilitation).
Mortality Rate
Low directly from smoker's cough; high if it progresses to severe smoking-related diseases such as COPD, lung cancer, or cardiovascular disease.
Risk of Secondary Damages
Very high probability of progression to chronic bronchitis, emphysema, COPD, pneumonia, lung cancer, and increased risk of cardiovascular diseases and stroke.
Probability of Full Recovery
High with complete smoking cessation, particularly in early stages before significant irreversible lung damage occurs; symptoms improve considerably even in later stages.
Underlying Disease Risk
Very high probability of developing underlying smoking-related diseases such as chronic bronchitis, emphysema, COPD, lung cancer, cardiovascular diseases, and stroke.